Frontlight ResearchEarly access
Parkinson disease trials in China
70 of 102 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in ChinaRemotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease
- Where
- Shanghai
- Age
- 40 years to 80 years
- People
- 98
- Run by
- Shanghai University of Sport
See details and how to joinNCT07518290 - Phase 2Taking peopleStudy to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
- Where
- Shanghai
- Age
- 40 years to 85 years
- People
- 474 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07781644 · EU 2025-524064-37-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Where
- Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Nanjing, Shanghai, Suzhou, Tianjin, Xi'an, Xuzhou
- Age
- 50 years to 85 years
- People
- 900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00 - Phase 1/2Taking peoplePhase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
- Where
- Shanghai
- Age
- 30 years to 75 years
- People
- 12
- Run by
- Shanghai UniXell Biotechnology Co., Ltd
See details and how to joinNCT07733349 - Early phase 1Taking peopleExploratory Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
- Where
- Hefei
- Age
- 30 years to 75 years
- People
- 12
- Run by
- The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07911670 - Phase 1Not yet taking people in ChinaA Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBS
- Where
- Beijing
- Age
- 40 years to 70 years
- People
- 12
- Run by
- Nuwacell Biotechnologies Co., Ltd.
See details and how to joinNCT07896187 - Phase 2/3Taking peopleVG081821AC Tablets for Early to Mid-stage Parkinson's Disease
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 152
- Run by
- Zhejiang Vimgreen Pharmaceuticals, Ltd.
See details and how to joinNCT07725562 - Phase 1Taking peopleA Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA
- Where
- Shanghai, Wuxi
- Age
- 18 years and over
- People
- 30
- Run by
- Synusight Biotech (Shanghai) Co., Ltd.
See details and how to joinNCT07604116 - No phaseTaking peopleSTN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's Disease
- Where
- Shanghai
- Age
- 50 years to 85 years
- People
- 60
- Run by
- Ruijin Hospital
See details and how to joinNCT07774312 - Phase 3Not yet taking people in ChinaPhase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
- Where
- Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Huzhou, Jiaxing, Lishui, Shanghai, Suzhou, Taizhou, Wenzhou, Wuhan, Zhengzhou
- Age
- 18 years to 80 years
- People
- 300
- Run by
- Hangzhou PhecdaMed Co., Ltd.
See details and how to joinNCT07741045 - No phaseTaking peopleDifferent Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease
- Where
- Guangzhou
- People
- 40
- Run by
- Ke Dong, MD
See details and how to joinNCT07721688 - Phase 1Taking peopleA Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
- Where
- Beijing, Chengdu, Shanghai Shi
- Age
- 35 years to 85 years
- People
- 10
- Run by
- H. Lundbeck A/S
See details and how to joinNCT07513441 - Phase 1Taking peopleA Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease
- Where
- Shanghai
- Age
- 40 years to 70 years
- People
- 18
- Run by
- Shanghai Xinzhi BioMed Co., Ltd.
See details and how to joinNCT07195825 - No phaseTaking peopleComparative Study of TIS Efficacy Across Different Targets
- Where
- Wuhan
- Age
- 40 years and over
- People
- 18
- Run by
- Zhongnan Hospital
See details and how to joinNCT07745673 - No phaseTaking peopleRemote Ischemic Conditioning for Sleep Disturbances and Other Non-motor Symptoms in Parkinson's Disease
- Where
- Nanjing
- Age
- 50 years to 70 years
- People
- 48
- Run by
- Jiangsu Province Nanjing Brain Hospital
See details and how to joinNCT07299240 - No phaseTaking people40 Hz Flickering for Insomnia in Parkinson's Disease
- Where
- Nanjing
- Age
- 50 years to 75 years
- People
- 30
- Run by
- Jiangsu Province Nanjing Brain Hospital
See details and how to joinNCT07323121 - Phase 1Not yet taking people in ChinaZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease
- Where
- Jinan
- Age
- 40 years to 70 years
- People
- 8
- Run by
- Qianfoshan Hospital
See details and how to joinNCT07718659 - No phaseTaking peopleAccelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome
- Where
- Guangzhou
- Age
- Up to 85 years
- People
- 60
- Run by
- Ke Dong, MD
See details and how to joinNCT07568067 - No phaseTaking peopleDirectional PSA Versus STN DBS for TD-PD
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 32
- Run by
- Ruijin Hospital
See details and how to joinNCT07700862 - No phaseEnrolling by invitationTemporal Interference Noninvasive Deep Brain Stimulation for Idiopathic Parkinson's Disease and Parkinsonian Syndromes: Effects and Target Exploration
- Where
- Shanghai
- Age
- 40 years to 80 years
- People
- 100
- Run by
- Ruijin Hospital
See details and how to joinNCT07698236 - Early phase 1Not yet taking people in ChinaA Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations
- Where
- Hefei
- Age
- 30 years to 70 years
- People
- 18
- Run by
- Lingyi Biotech Co., Ltd.
See details and how to joinNCT07685444 - Phase 1Taking peopleSafety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease
- Where
- Beijing
- Age
- 30 years to 85 years
- People
- 6
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT05901818 - No phaseTaking peopleIndividualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
- Where
- Beijing
- Age
- 30 years to 80 years
- People
- 50
- Run by
- Peking University First Hospital
See details and how to joinNCT07570212 - No phaseTaking peopleAdaptive DBS for PD
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Hefei, Jinan, Nanjing
- Age
- 18 years and over
- People
- 60
- Run by
- Beijing Pins Medical Co., Ltd
See details and how to joinNCT07635823 - No phaseNot yet taking people in ChinaImmediate Effects of External Trigeminal Nerve Stimulation on Motor Dysfunction in Parkinson's Disease
- Where
- Xi'an
- Age
- 40 years to 80 years
- People
- 30
- Run by
- Zhengli Di
See details and how to joinNCT07656129